🤯 Picked by our AI, this stock rallied more than Nvidia this month, yielding 94% since MarchSee the stock

Aurora Cannabis secures Australia GMP certification

EditorEmilio Ghigini
Published 03/20/2024, 07:25 AM
© Reuters.
ACB
-

EDMONTON, AB - Aurora Cannabis Inc. (NASDAQ: NASDAQ:ACB) (TSX: ACB), a Canadian-based global leader in medical cannabis, has been awarded Good Manufacturing Practice (GMP) certification by Australia's Therapeutic Goods Administration (TGA) for its production facilities, River and Ridge, located in Canada.

This certification, effective as of March 15, 2024, allows Aurora to export a broader range of cannabis products to the Australian market, including dried flower, resin cartridges, pastilles, and oils, in compliance with TGA regulations and TGO 93 standards.

The company's Vice President of Quality, Gorana Lakic, expressed pride in the achievement, emphasizing Aurora's commitment to quality and compliance. The certification is seen as a reinforcement of Aurora's dedication to the Australian medical cannabis market, which is currently estimated to be worth $400 million AUD and is the largest such market outside of North America.

Aurora, which is also the parent company of MedReleaf Australia, plans to continue introducing innovative products to the Australian market. Both Aurora and MedReleaf Australia are committed to providing Australian patients with reliable access to high-quality medical cannabis products and offering doctors a wider range of patient care options.

The company, known for its extensive portfolio of medical and recreational cannabis brands, operates in Canada, Europe, Australia, and South America. It is recognized for its science-driven approach and high-quality product offerings in the medical, wellness, and adult recreational markets.

This news release contains forward-looking statements regarding the company's intentions to grow and develop the Australian medical cannabis market further and to comply with regulatory standards. These statements are based on assumptions that management considers reasonable and are subject to risks and uncertainties that could cause actual results to differ materially.

The information in this article is based on a press release statement from Aurora Cannabis Inc.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.